Statement of Changes in Beneficial Ownership (4)
September 20 2021 - 2:30PM
Edgar (US Regulatory)
FORM 4
[ ]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0287
Estimated average burden hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
BHATIA NAVEEN |
2. Issuer Name and Ticker or Trading Symbol
LifeMD, Inc.
[
LFMD
]
|
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director _____ 10% Owner _____ Officer (give title below) _____ Other (specify below)
|
(Last)
(First)
(Middle)
823 GREENTREE RD |
3. Date of Earliest Transaction
(MM/DD/YYYY)
9/8/2021 |
(Street)
PACIFIC PALISADES, CA 90272
(City)
(State)
(Zip)
|
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
|
1.Title of Security (Instr. 3)
|
2. Trans. Date
|
2A. Deemed Execution Date, if any
|
3. Trans. Code (Instr. 8)
|
4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)
|
5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)
|
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)
|
7. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
Amount
|
(A) or (D)
|
Price
|
Common Stock | 9/15/2021 | | X | | 96349 | A | $1.75 | 96349 | D | |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Trans. Date | 3A. Deemed Execution Date, if any | 4. Trans. Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) |
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
Stock Option (Right to Buy) (2) | $7.07 | 9/8/2021 | | A | | 100000 | | 9/8/2021 | 9/8/2021 | Common Stock | 100000 | $0.00 | 100000 | D | |
Restricted Stock Unit | $0.00 | 9/8/2021 | | A | | 8000 | | (1) | (1) | Common Stock | 8000 | $0.00 | 8000 | D | |
Warrant (Right to Buy) | $1.75 | 9/15/2021 | | G | | 96349 | | 9/15/2021 | 1/12/2022 | Common Stock | 96349 | $0.00 | 96349 | D | |
Warrant (Right to Buy) | $1.75 | 9/15/2021 | | X | | | 96349 | 9/15/2021 | 1/12/2022 | Common Stock | 96349 | $0.00 | 0 | D | |
Explanation of Responses: |
(1) | Pursuant to the Company's 2020 Equity and Incentive Plan, as amended, the Director received a one-time grant of 8,000 Restricted Stock Units ("RSUs"), vesting quarterly with 25% vesting on September 30, 2021 and the remaining vesting ratably on December 31, 2021, March 31, 2022 and on the earlier of the annual stockholders' meeting or June 30, 2022. The RSUs represent a contingent right to receive one share of Common Stock for each RSU. |
(2) | Mr. Bhatia received an option to purchase 100,000 shares of Common Stock, at an exercise price of $7.07 per share, as compensation for services to be provided pursuant to a Consulting Agreement dated September 8, 2021. |
Reporting Owners
|
Reporting Owner Name / Address | Relationships |
Director | 10% Owner | Officer | Other |
BHATIA NAVEEN 823 GREENTREE RD PACIFIC PALISADES, CA 90272 | X |
|
|
|
Signatures
|
/s/ Naveen Bhatia | | 9/20/2021 |
**Signature of Reporting Person | Date |
LifeMD (NASDAQ:LFMD)
Historical Stock Chart
From Aug 2024 to Sep 2024
LifeMD (NASDAQ:LFMD)
Historical Stock Chart
From Sep 2023 to Sep 2024